D-dimer and Beyond: Harnessing the Potential of New Coagulation Indicators in COVID-19 Management

Intern Med. 2023 Oct 15;62(20):2929-2930. doi: 10.2169/internalmedicine.2355-23. Epub 2023 Aug 2.

Authors

Eiji Shibahashi¹, Kentaro Jujo^{1

2}

Affiliations

¹ Department of Cardiology, Tokyo Women's Medical University, Japan.
² Department of Cardiology, Saitama Medical University, Saitama Medical Center, Japan.

No abstract available

Keywords: COVID-19; coagulopathy; fibrin monomer complexes; thromboembolism.

MeSH terms

Blood Coagulation
Blood Coagulation Disorders* / diagnosis
COVID-19*
Disseminated Intravascular Coagulation*
Fibrin Fibrinogen Degradation Products
Humans

Substances

fibrin fragment D
Fibrin Fibrinogen Degradation Products